The Risk of Transfusion-Transmitted Viral Infections
New England Journal of MedicinePublished 27 June 1996
George B. Schreiber, Michael P. Busch, Steven Kleinman, James Korelitz
Citations1,894
SJR quartileQ1
SJR score19.08
SNIP13.47
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The risk of transmitting HIV, HTLV, HCV, or HBV infection by the transfusion of screened blood is very small, and new screening tests will reduce the risk even further.
Abstract
The risk of transmitting HIV, HTLV, HCV, or HBV infection by the transfusion of screened blood is very small, and new screening tests will reduce the risk even further.
Keywords
Immunology and MicrobiologyAgricultural and Biological SciencesMedicine
PubMedSurveillance for waterborne-disease outbreaks--United States, 1993-1994.
2,055 Citations1996Michael H. Kramer, Barbara L. Herwaldt +3 more
The outbreaks of cryptosporidiosis in Milwaukee and Las Vegas demonstrate that WBDOs can occur in large metropolitan areas and were associated with deaths among immunocompromised persons.
New England Journal of MedicineDetection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B Hepatitis
1,684 Citations1989Harvey J. Alter, Robert H. Purcell +5 more
It is concluded that hepatitis C virus is the predominant agent of transfusion-associated non-A, non-B hepatitis and that screening of donors for anti-HCV could prevent the majority of cases of the disease.
New England Journal of MedicineThe Natural History of Community-Acquired Hepatitis C in the United States
1,616 Citations1992Miriam J. Alter, Harold S. Margolis +10 more
Patients with community-acquired hepatitis C have a high rate of chronic hepatitis, and in most patients HCV infection seems to persist for at least several years, even in the absence of active liver disease.
New England Journal of MedicineLong-Term Mortality after Transfusion-Associated Non-A, Non-B Hepatitis
685 Citations1992Leonard B. Seeff, Zelma Buskell‐Bales +10 more
There was no increase in mortality from all causes after transfusion-associated non-A, non-B hepatitis, although there was a small but statistically significant increase in the number of deaths related to liver disease.
New England Journal of MedicineA Long-Term Study of Hepatitis C Virus Replication in Non-A, Non-B Hepatitis
573 Citations1991Patrizia Farci, Harvey J. Alter +5 more
The disappearance of HCV RNA from serum appears to correlate with the resolution of non-A, non-B hepatitis, whereas viremia persists in patients whose disease progresses to chronic hepatitis.
New England Journal of MedicineHepatitis C Virus Infection in Post-Transfusion Hepatitis
531 Citations1991Richard D. Aach, Cladd E. Stevens +7 more
PubMedMaternal mortality surveillance, United States, 1980-1985.
513 Citations1988Lisa M. Koonin, H K Atrash +2 more
Overall, women over 30 years of age had a higher risk of dying than did younger women, and women of black and other races who were 30 years and older having the highest risk.
New England Journal of MedicineSerum Alanine Aminotransferase of Donors in Relation to the Risk of Non-A,Non-B Hepatitis in Recipients
487 Citations1981Richard D. Aach, W. Szmuness +6 more
Screening blood for ALT levels would reduce the incidence of non-A,non-B post-transfusion hepatitis, according to the Transfusion-Transmitted Viruses Study.
TransfusionTime course of detection of viral and serologic markers preceding human immunodeficiency virus type 1 seroconversion: implications for screening of blood and tissue donors
365 Citations1995Michael P. Busch, L. L. L. Lee +7 more
Recent improvement in the sensitivity of anti‐HIV assays has resulted in significant shortening of the preseroconversion window period, and the incremental reduction in the window period that could be achieved by implementing direct virus‐detection Assays has diminished significantly.
New England Journal of MedicineEstimated Risk of Transmission of the Human Immunodeficiency Virus by Screened Blood in the United States
357 Citations1995Eve Lackritz, Glen A. Satten +7 more
The estimated risk of transmitting HIV by the transfusion of screened blood is very small and nearly half that estimated previously, primarily because the sensitivity of enzyme immunosorbent assays has been improved.
BloodTo C or not to C: these are the questions
284 Citations1995HJ Alter
There is early evidence for a non-A, B, C agent that can be transmitted to tamarin, if sera from hepatitis-associated aplastic anemia cases should be inoculated into this study.
New England Journal of MedicineExposure of Patients to Human Immunodeficiency Virus through the Transfusion of Blood Components That Test Antibody-Negative
247 Citations1989Paul Cumming, Edward L. Wallace +2 more
It is estimated that donor-recruitment practices plus careful education and screening are eliminating 49 of every 50 donors likely to be HIV-positive and that testing is 92 to 97 percent effective, for a combined effectiveness of 99.9 percent.
International Journal of CancerA prospective study of transmission by transfusion of HTLV‐I and risk factors associated with seroconversion
245 Citations1992Angela Manns, Rainford Wilks +6 more
It is confirmed that blood transfusion carries a significant risk of HTLV‐I transmission and that screening of donor blood effectively prevents HTLV-I seroconversion, and patients who required multiple transfusions or were receiving immunosuppressive therapy at the time of transfusion are given priority in receiving selectively screened blood components.
JAMADonor transaminase and recipient hepatitis. Impact on blood transfusion services
218 Citations1981Harrison Alter
Annals of Internal MedicineInfection with Human Immunodeficiency Virus Type 1 (HIV-1) among Recipients of Antibody-Positive Blood Donations
190 Citations1990Elizabeth Donegan, Maria Stuart +15 more
Transfusion of anti-HIV-1-positive blood infected 90% of recipients and the rate of progression to AIDS within the first 38 months after infection was similar to that reported for homosexual men and hemophiliacs.
New England Journal of MedicineEvaluation of Screened Blood Donations for Human Immunodeficiency Virus Type 1 Infection by Culture and DNA Amplification of Pooled Cells
171 Citations1991Michael P. Busch, Bernard E. Eble +7 more
Silent HIV-1 infections are exceedingly rare among screened blood donors, so the current risk of HIV- 1 transmission from blood transfusions, even in high-prevalence metropolitan areas, is extremely low.
TransfusionIncreased detection of hepatitis C virus (HCV)‐infected blood donors by a multiple‐antigen HCV enzyme immunoassay
163 Citations1992Steven Kleinman, HarveyT. Alter +8 more
The data indicate that EIA‐2 testing will significantly reduce, but probably not eliminate, the risk of transfusion‐associated HCV infection; the residual per‐unit risk is estimated to be 1 in 2000 to 1 in 6000 units transfused.
TransfusionDuration of time from onset of human immunodeficiency virus type 1 infectiousness to development of detectable antibody
161 Citations1994Line Petersen, Glen A. Satten +6 more
For persons newly infected with the human immunodeficiency virus type 1, the time from the onset of infectivity to the development of detectable HIV‐1 antibody is unknown, and persons who donate blood during this period account for nearly all instances of HIV-1 transmission from HIV‐ 1 antibody‐screened blood transfusions.
TransfusionTransfusion transmission of retroviruses: human T‐lymphotropic virus types I and II compared with human immunodeficiency virus type 1
143 Citations1994Elizabeth Donegan, Hung Ming Lee +10 more
The results show that transfusion transmission of human T‐ lymphotropic virus type I and HTLV type II has not been compared directly or to that of human immunodeficiency virus type 1 (HIV‐1).
BMJEffect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.
142 Citations1993Larry Mimms, James W. Mosley +7 more
Acute coinfection with hepatitis C virus and hepatitis B virus inhibits hepatitis Birus infection in humans, and onset of hepatitis B may reduce the severity of hepatitis Cirus infection but not frequency of chronicity.
New England Journal of MedicinePrevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening
129 Citations1990Harvey J. Alter, Jay S. Epstein +10 more
TransfusionDeclining value of alanine aminotransferase in screening of blood donors to prevent posttransfusion hepatitis B and C virus infection. The Retrovirus Epidemiology Donor Study
126 Citations1995Michael P. Busch, James Korelitz +4 more
The present study was designed to quantitate the residual value of ALT screening following the implementation of hepatitis C virus (HCV) assays.
Annals of Internal MedicineTransmission of Retroviruses from Seronegative Donors by Transfusion during Cardiac Surgery
102 Citations1992Kenrad E. Nelson, James G. Donahue +12 more
Serologic screening of donors for antibodies to HIV-1 and HTLV-I coupled with exclusion of donors from groups having a relatively high risk for infection has led to a low incidence of transfusion-transmitted HIV- said to be about 1 in 60,000 units.
TransfusionFalse‐positive human immunodeficiency virus type 1 western blot tests in noninfected blood donors
73 Citations1996Keith R. Sayre, Roger Y. Dodd +4 more
The present study was conducted to verify the existence of false‐positive WBs among noninfected donors and to assess the extent of this problem.
BloodAccuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study
72 Citations1994MP Busch, Megan E. Laycock +6 more
Journal of Medical VirologyPatterns of serological markers in transfusion‐transmitted hepatitis C virus infection using second‐generation HCV assays
68 Citations1992P.N. Lelie, H. T. M. Cuypers +8 more
It is concluded that combined application of anti‐HCV immunoblot techniques and cDNA‐PCR in consecutive samples is necessary for reliable diagnosis of either ongoing productive or resolving HCV infection.
BloodAccuracy of supplementary serologic testing for human T-lymphotropic virus types I and II in US blood donors. Retrovirus Epidemiology Donor Study
65 Citations1994MP Busch, Megan E. Laycock +6 more
Recommendations that HTLV-I/II-seropositive donors should be advised that they are infected with HTLV, HTLV/II, or HT LV/II (depending on results of type-specific assays) are supported.
TransfusionDemographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study
55 Citations1994James Korelitz, Alan Williams +5 more
The current CUE process has low sensitivity and apparently low positive predictive value, and in many cases, it appeared that donors misunderstood it, which suggests that efforts to improve the CUE system may be warranted.
BloodHuman T-cell leukemia virus type II infection frequently goes undetected in contemporary US blood donors
53 Citations1993BRIAN HJELLE, Chris Wilson +6 more
The donation histories of the first 60 Western blot-confirmed HTLV-I/II positive donors to one blood center were examined and found 8 had made 16 previous donations that scored negative on the screening ELISA, which missed at least 10 of 23, or 43% (95% confidence interval, 23% to 66%), ofHTLV-II infections.
Clinical Infectious DiseasesHepatitis C: Natural History of a Unique Infection
50 Citations1995Sten Iwarson, Gunnar Norkrans +1 more
The failure to demonstrate protective immunity after single or multiple episodes of infection raises doubts about the existence of neutralizing antibodies and concerns about the potential for the development of a vaccine against HCV.
TransfusionA pattern of 5‐1‐1 and c100‐3 only on hepatitis C virus (HCV) recombinant immunoblot assay does not reflect HCV infection in blood donors
34 Citations1993Michael P. Busch, Leslie H. Tobler +9 more
It is concluded that, in the blood donor setting, a pattern of only 5‐1‐1 and c100‐3 reactivity is typically not indicative of HCV infection and it is recommended that RIBA grading criteria be revised to require reactivity to two or more HCV‐encoded gene products.
Transfusion MedicineA multicentre assessment of the specificity of ten anti‐HBc screening tests
32 Citations1995Walter Hughes, Andrew Barr +3 more
Samples from 1828 donations were screened for anti‐HBc at seven sites in the UK using kits supplied by 10 manufacturers, and additional markers of HBV infection were found in nine of these 10 donations.
Journal of Clinical MicrobiologyEvaluation of a p21e-spiked western blot (immunoblot) in confirming human T-cell lymphotropic virus type I or II infection in volunteer blood donors. The Retrovirus Epidemiology Donor Study Group
30 Citations1994Steven Kleinman, J E Kaplan +4 more
Although the p21e WB used in this study has high sensitivity and may be useful as a confirmatory assay in epidemiologic research studies, it may not be ideal as a confirmation test for the notification of blood donors.
TransfusionSterility of plastic tubing welds in components stored at room temperature
20 Citations1995James P. AuBuchon, Chris J. Pickard +1 more
The ability of the sterile connecting device to maintain a closed system in the welding of blood component units to be maintained at room temperature is documented.
Journal of Acquired Immune Deficiency Syndromes & Human RetrovirologyHuman Immunodeficiency Virus Type-1 Seroconversion Trends Among Young Adults Serving in the United States Army, 1985-1993
16 Citations1995Philip O. Renzullo, John G. McNeil +3 more
Monitoring the rate of new HIV-1 infections allows for identification of subgroups in need of intervention, refocusing of intervention strategies, and evaluation of their effectiveness.